Showing results (11-20 of 51) with videos related to

Sort By:
Pageof 6
Expert Opinion on Biological Therapy|July 10, 2019
Which place for avelumab in the management of urothelial carcinoma?Mathieu Larroquette, Marine Gross-Goupil, Amaury Daste, et al.
Therapeutics and Clinical Risk Management|June 9, 2022
An Evaluation of Cabozantinib for the Treatment of Renal Cell Carcinoma: Focus on Patient Selection and PerspectivesRomain Iaxx, Felix Lefort, Charlotte Domblides, et al.
Cancers|May 11, 2024
How Immunotherapy Has Redefined the Treatment Paradigm of Metastatic or Locally Advanced Muscle-Invasive Urothelial Bladder CarcinomaMathieu Larroquette, Félix Lefort, Charlotte Domblides, et al.
European Journal of Cancer (Oxford, England : 1990)|November 18, 2016
Targeted therapy and elderly people: A reviewAmaury Daste, Camille Chakiba, Charlotte Domblides, et al.
Cells|November 8, 2024
Myeloid-Derived Suppressor Cells in Bladder Cancer: An Emerging TargetClément Klein, Samy Mebroukine, Mathilde Madéry, et al.
Bulletin Du Cancer|December 23, 2017
[Lung cancer in HIV-infected patients]Charlotte Domblides, Anthony Canellas, Marie Wislez, et al.
Cancer Treatment Reviews|April 27, 2021
Adjuvant therapy in renal cell carcinoma: Current knowledges and future perspectivesMathieu Larroquette, Florent Peyraud, Charlotte Domblides, et al.
Expert Opinion on Drug Safety|June 11, 2020
Safety of sunitinib in patients with renal cell carcinoma following nephrectomyLuc Heraudet, Charlotte Domblides, Amaury Daste, et al.
Expert Opinion on Biological Therapy|April 5, 2020
Atezolizumab for the treatment of renal cell carcinomaMathilde Lafon, Charlotte Domblides, Amaury Daste, et al.
Cancers|December 23, 2022
Therapeutic Management of Metastatic Clear Cell Renal Cell Carcinoma: A Revolution in Every DecadeMathieu Larroquette, Félix Lefort, Luc Heraudet, et al.
Pageof 6